Paul Eckburg - Chief Medical Officer at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
ANTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paul Eckburg since 9/19/2023

Holdings reported by Paul Eckburg for AN2 Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 51.4K $983K $19.11 Mar 15, 2024 Direct
Stock Option (right to buy) 60K Mar 15, 2024 Direct Common Stock
Common 51.4K Mar 15, 2024 Direct

Transactions reported by Paul Eckburg for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.